Efficacy and safety of a combination treatment of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis

CONCLUSION: Pooled therapy had improved PFS in mTNBC patients, especially in patients with PD-L1-positive tumors, and it was less likely to cause grade ≥ 3 AEs.PMID:38587602 | DOI:10.1007/s12094-024-03396-6

Source: Clinical Breast Cancer - April 8, 2024 Category: Cancer & Oncology Authors: Ying Wang Yalan Sun Fang Lu Xianghong Zhao Zhenlin Nie Feng Zhu Bangshun He Source Type: research